These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 5252042

  • 1. [A new antineoplastic drug: the L-asparaginase. Future possibilities of antitumor enzymotherapy].
    Nervi C, Casale C, Cortese M.
    Policlinico Prat; 1969 Mar 10; 76(10):297-304. PubMed ID: 5252042
    [No Abstract] [Full Text] [Related]

  • 2. [Antineoplastic activity of L-asparaginase].
    Grgić Z.
    Lijec Vjesn; 1969 Jul 10; 91(7):783-6. PubMed ID: 4910066
    [No Abstract] [Full Text] [Related]

  • 3. [L-asparaginase--first specific cytostatic].
    Marquardt H.
    Arzneimittelforschung; 1968 Nov 10; 18(11):1380-6. PubMed ID: 4885156
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Combination therapy studies with L-asparaginase (NSC-109229) and other antitumor agents.
    Jacobs SP, Wodinsky I, Kensler CJ, Venditti JM.
    Cancer Chemother Rep; 1970 Oct 10; 54(5):329-35. PubMed ID: 5514622
    [No Abstract] [Full Text] [Related]

  • 7. [The antitumor activity of L-asparaginase].
    Adamson RH, Fabro S.
    Acta Vitaminol Enzymol; 1969 Oct 10; 23(3):111-24. PubMed ID: 4897937
    [No Abstract] [Full Text] [Related]

  • 8. L-asparaginase bound to collagen membrane in an extracorporeal device: an intermittent antitumor enzyme therapy delivery system.
    Joyeuse R, Kim HC, Saidi P, McBride KJ, Jefferies SR, Bernath FR.
    Surg Forum; 1976 Oct 10; 27(62):115-6. PubMed ID: 1019820
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Immobilized asparaginase and its use in medicine].
    Kozlov EA, Petriĭ OP.
    Vopr Med Khim; 1978 Oct 10; 24(6):723-33. PubMed ID: 32657
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Initial results of the use of L-asparaginase in acute leukemia in childhood].
    Nigro N, Madon E, Baroncelli PG.
    Minerva Pediatr; 1970 Mar 17; 22(11):536-9. PubMed ID: 5267828
    [No Abstract] [Full Text] [Related]

  • 15. [To what extent L-asparaginase affects the tumor cells? Press information of the Sektion Onkologie der Paul-Ehrlich-Gesellschaft für Chemotherapie].
    Munch Med Wochenschr; 1969 Sep 12; 111(37):Suppl 37:1+. PubMed ID: 5260991
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Therapeutic properties of a new glutaminase-asparaginase preparation and the influence of the lactate dehydrogenase-elevating virus.
    Riley V, Spackman D, Fitzmaurice MA, Roberts J, Holcenberg JS, Dolowy WC.
    Cancer Res; 1974 Feb 12; 34(2):429-38. PubMed ID: 4810909
    [No Abstract] [Full Text] [Related]

  • 18. Enzyme therapy of cancer, future studies.
    Holcenberg JS.
    Cancer Treat Rep; 1981 Feb 12; 65 Suppl 4():61-5. PubMed ID: 7346158
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Cytostatic effect of L-asparaginase].
    Rakowska-Wódz A, Szyszka K, Abucewicz A.
    Wiad Lek; 1970 Jan 15; 23(2):117-20. PubMed ID: 4985374
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.